CD8A

There are 608 papers on CD8A in aging research: 38 trials and 343 observational studies in people, 172 in animals, 12 in cells, 29 reviews. The newest story, Nov 11, 2026: “Uneven T cell division linked to better vaccine responses”.

Gene

608 papers study it4 findings

HGNCNCBI GeneTaxon

9 new papers in 30 daysSee all 608 papers on CD8A

At a glance

The findings reach people, from one lab or study. 3 independent labs in 2 countries.

“T cell lag3 and cd8a were associated with worse IADLs, QoL, and SPPB scores at baseline.”
The FITNESS study: longitudinal geriatric assessment, treatment toxicity, and biospecimen collection to assess functional disability among older adults with lung cancerFrontiers in aging2024doi:10.3389/fragi.2024.1268232

None of its findings points the other way.

Mice and humans: a single group. Cells and worms or flies: nothing yet.
  • 3 independent labs in 2 countries
  • Funders: Bristol Myers Squibb and 5 more
  • Human trial38
  • Humans343
  • Animals172
  • Cells12
  • In silico8

Effects

1

Survival

is required forin mice1

1 study
  1. CD8A is required for survival in mice (for survival benefit of anti-PD1 checkpoint blockade during NME).

    Animalsfor survival benefit of anti-PD1 checkpoint blockade during NME

Associations

3

Neuronal survival

downin mice1

1 study
  1. CD8A is associated with neuronal survival in mice (MPTP-treated mice).

    AnimalsMPTP-treated micesubstantia nigra

Physical function

downin humans1

1 study
  1. CD8A is associated with physical function in humans (baseline in older adults with non-small-cell lung cancer).

    Humansbaseline in older adults with non-small-cell lung cancern = 50

Telomere length

mixedin silico1

1 study
  1. Telomere length is associated with CD8A in silico (35 proteins).

    In silico

More on Telomere length

Latest

Dec 2025: 16Jan 2026: 16Feb 2026: 14Mar 2026: 14Apr 2026: 13May 2026: 5Jun 2026: 11Jul 2026: 12Aug 2026: 4Sep 2026: 2Oct 2026: 7Nov 2026: 4118 papers in 12 months
Science Advances

Uneven T cell division linked to better vaccine responses

People in an influenza vaccine trial had better responses when their dividing T cells shared cellular recycling machinery more unequally.People in an influenza vaccine trial had better responses when their dividing T cells shared cellular recycling machinery more unequally.

Cohort · 12 peopleImmune response

See all 608 papers on CD8A